Related Experiment Videos

Expression of membrane-type matrix metalloproteinase in human gastric carcinomas

H Nomura1, H Sato, M Seiki

  • 1Department of Molecular Immunology and Pathology, Kanazawa University, Ishikawa, Japan.

Cancer Research
|August 1, 1995
PubMed

Insights

Membrane-type matrix metalloproteinase (MT-MMP) exclusively activates matrix metalloproteinase-2 (MMP-2) zymogen in human gastric carcinoma. This MT-MMP-assisted activation occurs specifically within carcinoma cells expressing MT-MMP.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) play crucial roles in tumor progression.
  • MMP-2 activation is a key step in cancer development.
  • The role of membrane-type MMPs (MT-MMPs) in gastric cancer requires further elucidation.

Purpose of the Study:

  • To investigate the role of MT-MMP in the activation of MMP-2 zymogen (proMMP-2) in human gastric carcinoma.
  • To determine the expression patterns and localization of MT-MMP and proMMP-2 in gastric cancer tissues.

Main Methods:

  • Northern blot analysis to assess MT-MMP gene expression.
  • Immunohistochemistry to visualize MT-MMP and MMP-2 protein localization.
  • Gelatin zymography to evaluate proMMP-2 activation.
  • Microdissection to pinpoint the site of proMMP-2 activation.

Main Results:

  • MT-MMP was exclusively expressed in human gastric carcinoma tissues.
  • MT-MMP colocalized with MMP-2 in most carcinoma cells (13 of 14 cases).
  • ProMMP-2 activation correlated with MT-MMP expression and occurred specifically in MT-MMP-expressing carcinoma cell nests.

Conclusions:

  • MT-MMP is responsible for the activation of proMMP-2 in human gastric carcinoma.
  • This MT-MMP-assisted activation is localized to carcinoma cells, not normal gastric mucosa.
  • The findings highlight MT-MMP as a key player in gastric cancer progression.

Related Concept Videos